Rachel H Clare
My current research, including my Directors Catalyst Fund (opens in a new tab)award, is focused on drug discovery for novel small-molecule based treatments for snakebite. Through the scale up of inhouse assays we are building a diversity drug discovery programme to identify novel compounds with inhibitory activity against common venom toxins.
Abstracts this author is presenting:
